Arzneiformen

T Wimmer, M Van Ooteghem, W Schneider…

Index: Kawamura Yakugaku Zasshi, 1938 , vol. 58, p. 405,410; dtsch. Ref. S. 83 Chem. Zentralbl., 1939 , vol. 110, # I p. 130

Full Text: HTML

Citation Number: 0

Abstract

... Proc 5th Int Conf Pharm Technology (APGI), Paris, Vol. 1, p 313–321. 169. ... Bowman FW, Holdowsky S (1959) J Am Pharm Assoc Sei Ed 48:95–96. 246. Bowman FW (1969) J Pharm Sei 58:277–278. 247. ... 257. Frauch P (1970) Pharm Acta Helv 45:75–88PubMed. 258. ...

Antioxidant constituents from rhubarb: structural requiremen...

[Matsuda, Hisashi; Morikawa, Toshio; Toguchida, Iwao; Park, Ji-Young; Harima, Shoichi; Yoshikawa, Masayuki Bioorganic and Medicinal Chemistry, 2001 , vol. 9, # 1 p. 41 - 50]

Spasmolytic Effects, Mode of Action, and Structure-Activity ...

[Hernandez-Romero, Yanet; Rojas, Juana-Isela; Castillo, Rafael; Rojas, Alejandra; Mata, Rachel Journal of Natural Products, 2004 , vol. 67, # 2 p. 160 - 167]